Different long-term oncologic outcomes after radical surgical resection for neuroendocrine carcinoma and adenocarcinoma of the stomach.

about

Different long-term oncologic outcomes after radical surgical resection for neuroendocrine carcinoma and adenocarcinoma of the stomach.

Item

http://www.wikidata.org/entity/Q41341063

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Different long-term oncologic ...... adenocarcinoma of the stomach.

@en

type

Item

label

Different long-term oncologic ...... adenocarcinoma of the stomach.

@en

prefLabel

Different long-term oncologic ...... adenocarcinoma of the stomach.

@en

P1476

Different long-term oncologic ...... adenocarcinoma of the stomach.

@en

P2093

Chang-Ming Huang

http://www.w3.org/2001/XMLSchema#string

Chao-Hui Zheng

http://www.w3.org/2001/XMLSchema#string

Jia-Bin Wang

http://www.w3.org/2001/XMLSchema#string

Jian-Wei Xie

http://www.w3.org/2001/XMLSchema#string

Jian-Xian Lin

http://www.w3.org/2001/XMLSchema#string

Jun Lu

http://www.w3.org/2001/XMLSchema#string

Long-Long Cao

http://www.w3.org/2001/XMLSchema#string

Mi Lin

http://www.w3.org/2001/XMLSchema#string

Ping Li

http://www.w3.org/2001/XMLSchema#string

Qi-Yue Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors.

Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors

Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity.

Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?

Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma.

Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.

Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma.

The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories.

P304

57495-57504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.15488

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28915689

http://www.w3.org/2001/XMLSchema#string

P932

5593661

http://www.w3.org/2001/XMLSchema#string